[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f0ed2JwSctbaFru7pvf-6EguoC7ks1GlhEShSHAp3Ry4":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":57,"rows":64},"University of Pavia",[4],134,false,28,5,18084,8,111,[14,17,19,22,25,27,29,31],{"name":15,"count":16},"Periodontal Diseases",10,{"name":18,"count":11},"Peri-implant Mucositis",{"name":20,"count":21},"Hypertension",6,{"name":23,"count":24},"Essential Hypertension",4,{"name":26,"count":24},"Dental Plaque",{"name":28,"count":24},"Dental Caries",{"name":30,"count":24},"Dyslipidemias",{"name":32,"count":24},"Malnutrition",[34,39,44,48,52],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT07088679","Natural Bioactive Gel for Peri-Implantitis","2026-05-05","Sterify Gel",{"nctId":40,"briefTitle":41,"date":42,"intervention":43},"NCT07069166","Para-Probiotic Oral Care in Periodontal Patients With Type 2 Diabetes","2026-06-01","Para-probiotic oral care",{"nctId":45,"briefTitle":46,"date":42,"intervention":47},"NCT07069140","Lactoferrin-Based Oral Care for Periodontal Health in Pregnancy","Lactoferrin-based Toothpaste and Mouthwash",{"nctId":49,"briefTitle":50,"date":42,"intervention":51},"NCT07069218","Hydroxyapatite Toothpastes and Enamel Remineralization:","Biorepair® Total Protection Plus Toothpaste",{"nctId":53,"briefTitle":54,"date":55,"intervention":56},"NCT06950619","Associations Between Dental Anomalies and Ocular, Cutaneous and Skin Appendages Features","2027-04","Whole Genome Sequencing",[58,59,60,61,62,63],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[65,92,110,133,151,173,191,214,237,278,305,328,346,371,389,420,438,456,474,492,510,535,553,577,604,622,640,668,692,710,728,763,781,807,833,856,874,900],{"intervention":43,"totalTrials":66,"cells":67},1,{"EARLY_PHASE1":68,"PHASE1":71,"PHASE2":73,"PHASE3":75,"PHASE4":77,"NA":79},{"trials":69,"activeCount":70},[],0,{"trials":72,"activeCount":70},[],{"trials":74,"activeCount":70},[],{"trials":76,"activeCount":70},[],{"trials":78,"activeCount":70},[],{"trials":80,"activeCount":66,"soonestReadout":42},[81],{"nctId":40,"briefTitle":41,"status":82,"phases":83,"primaryCompletion":42,"completion":84,"start":85,"enrollment":86,"conditions":87,"interventions":90},"RECRUITING",[63],"2026-06-10","2025-07-30",40,[88,89],"Periodontitis","Type 2 Diabetes Mellitus (T2DM)",[43,91],"Chlorhexidine oral care",{"intervention":91,"totalTrials":66,"cells":93},{"EARLY_PHASE1":94,"PHASE1":96,"PHASE2":98,"PHASE3":100,"PHASE4":102,"NA":104},{"trials":95,"activeCount":70},[],{"trials":97,"activeCount":70},[],{"trials":99,"activeCount":70},[],{"trials":101,"activeCount":70},[],{"trials":103,"activeCount":70},[],{"trials":105,"activeCount":66,"soonestReadout":42},[106],{"nctId":40,"briefTitle":41,"status":82,"phases":107,"primaryCompletion":42,"completion":84,"start":85,"enrollment":86,"conditions":108,"interventions":109},[63],[88,89],[43,91],{"intervention":47,"totalTrials":66,"cells":111},{"EARLY_PHASE1":112,"PHASE1":114,"PHASE2":116,"PHASE3":118,"PHASE4":120,"NA":122},{"trials":113,"activeCount":70},[],{"trials":115,"activeCount":70},[],{"trials":117,"activeCount":70},[],{"trials":119,"activeCount":70},[],{"trials":121,"activeCount":70},[],{"trials":123,"activeCount":66,"soonestReadout":42},[124],{"nctId":45,"briefTitle":46,"status":82,"phases":125,"primaryCompletion":42,"completion":84,"start":85,"enrollment":86,"conditions":126,"interventions":131},[63],[127,128,129,130],"Pregnancy","Periodontal Disease","Gingivitis","Oral Microbiota",[47,132],"Lactoferrin-Based Toothpaste Only",{"intervention":132,"totalTrials":66,"cells":134},{"EARLY_PHASE1":135,"PHASE1":137,"PHASE2":139,"PHASE3":141,"PHASE4":143,"NA":145},{"trials":136,"activeCount":70},[],{"trials":138,"activeCount":70},[],{"trials":140,"activeCount":70},[],{"trials":142,"activeCount":70},[],{"trials":144,"activeCount":70},[],{"trials":146,"activeCount":66,"soonestReadout":42},[147],{"nctId":45,"briefTitle":46,"status":82,"phases":148,"primaryCompletion":42,"completion":84,"start":85,"enrollment":86,"conditions":149,"interventions":150},[63],[127,128,129,130],[47,132],{"intervention":51,"totalTrials":66,"cells":152},{"EARLY_PHASE1":153,"PHASE1":155,"PHASE2":157,"PHASE3":159,"PHASE4":161,"NA":163},{"trials":154,"activeCount":70},[],{"trials":156,"activeCount":70},[],{"trials":158,"activeCount":70},[],{"trials":160,"activeCount":70},[],{"trials":162,"activeCount":70},[],{"trials":164,"activeCount":66,"soonestReadout":42},[165],{"nctId":49,"briefTitle":50,"status":82,"phases":166,"primaryCompletion":42,"completion":84,"start":167,"enrollment":86,"conditions":168,"interventions":171},[63],"2025-07-25",[169,170],"Enamel Hypomineralization","Tooth Erosion",[51,172],"Bioniq® Toothpaste",{"intervention":172,"totalTrials":66,"cells":174},{"EARLY_PHASE1":175,"PHASE1":177,"PHASE2":179,"PHASE3":181,"PHASE4":183,"NA":185},{"trials":176,"activeCount":70},[],{"trials":178,"activeCount":70},[],{"trials":180,"activeCount":70},[],{"trials":182,"activeCount":70},[],{"trials":184,"activeCount":70},[],{"trials":186,"activeCount":66,"soonestReadout":42},[187],{"nctId":49,"briefTitle":50,"status":82,"phases":188,"primaryCompletion":42,"completion":84,"start":167,"enrollment":86,"conditions":189,"interventions":190},[63],[169,170],[51,172],{"intervention":38,"totalTrials":66,"cells":192},{"EARLY_PHASE1":193,"PHASE1":195,"PHASE2":197,"PHASE3":199,"PHASE4":201,"NA":203},{"trials":194,"activeCount":70},[],{"trials":196,"activeCount":70},[],{"trials":198,"activeCount":70},[],{"trials":200,"activeCount":70},[],{"trials":202,"activeCount":70},[],{"trials":204,"activeCount":66,"soonestReadout":37},[205],{"nctId":35,"briefTitle":36,"status":82,"phases":206,"primaryCompletion":37,"completion":207,"start":85,"enrollment":208,"conditions":209,"interventions":213},[63],"2026-05-30",20,[210,211,212],"Peri-implantitis","Dental Implants","Non-surgical Periodontal Therapy",[38],{"intervention":56,"totalTrials":66,"cells":215},{"EARLY_PHASE1":216,"PHASE1":218,"PHASE2":220,"PHASE3":222,"PHASE4":224,"NA":226},{"trials":217,"activeCount":70},[],{"trials":219,"activeCount":70},[],{"trials":221,"activeCount":70},[],{"trials":223,"activeCount":70},[],{"trials":225,"activeCount":70},[],{"trials":227,"activeCount":66,"soonestReadout":55},[228],{"nctId":53,"briefTitle":54,"status":229,"phases":230,"primaryCompletion":55,"completion":55,"start":231,"enrollment":9,"conditions":232,"interventions":236},"NOT_YET_RECRUITING",[63],"2026-02",[233,234,235],"Congenital Cataract","Tooth Abnormalities","Ocular Pathologies",[56],{"intervention":238,"totalTrials":239,"cells":240},"Ramipril",2,{"EARLY_PHASE1":241,"PHASE1":243,"PHASE2":245,"PHASE3":247,"PHASE4":263,"NA":276},{"trials":242,"activeCount":70},[],{"trials":244,"activeCount":70},[],{"trials":246,"activeCount":70},[],{"trials":248,"activeCount":70},[249],{"nctId":250,"briefTitle":251,"status":252,"phases":253,"primaryCompletion":254,"completion":255,"start":256,"enrollment":257,"conditions":258,"interventions":261},"NCT01230034","Antiproteinuric Effect of Imidapril Versus Ramipril in Type 2 Diabetic and Hypertensive Patients With Microalbuminuria","UNKNOWN",[61],"2011-06","2011-07","2010-10",206,[20,259,260],"Type 2 Diabetes Mellitus","Microalbuminuria",[238,262],"Imidapril",{"trials":264,"activeCount":70},[265],{"nctId":266,"briefTitle":267,"status":252,"phases":268,"primaryCompletion":269,"completion":254,"start":270,"enrollment":271,"conditions":272,"interventions":274},"NCT01038895","Aliskiren Versus Ramipril on Antiproteinuric Effect in Hypertensive, Type 2 Diabetic Patients With Microalbuminuria",[62],"2010-03","2009-11",120,[20,273],"Type 2 Diabetes",[238,275],"Experimental",{"trials":277,"activeCount":70},[],{"intervention":279,"totalTrials":66,"cells":280},"Uricemin",{"EARLY_PHASE1":281,"PHASE1":283,"PHASE2":285,"PHASE3":287,"PHASE4":289,"NA":303},{"trials":282,"activeCount":70},[],{"trials":284,"activeCount":70},[],{"trials":286,"activeCount":70},[],{"trials":288,"activeCount":70},[],{"trials":290,"activeCount":70},[291],{"nctId":292,"briefTitle":293,"status":294,"phases":295,"primaryCompletion":296,"completion":297,"start":298,"enrollment":299,"conditions":300,"interventions":302},"NCT04161872","Nutraceutical on Hyperuricemia","COMPLETED",[62],"2019-11-30","2019-12-31","2018-10-01",116,[301],"Hyperuricemia",[279],{"trials":304,"activeCount":70},[],{"intervention":306,"totalTrials":66,"cells":307},"aliskiren\u002Famlodipine",{"EARLY_PHASE1":308,"PHASE1":310,"PHASE2":312,"PHASE3":314,"PHASE4":316,"NA":326},{"trials":309,"activeCount":70},[],{"trials":311,"activeCount":70},[],{"trials":313,"activeCount":70},[],{"trials":315,"activeCount":70},[],{"trials":317,"activeCount":70},[318],{"nctId":319,"briefTitle":320,"status":252,"phases":321,"primaryCompletion":322,"completion":269,"start":270,"enrollment":323,"conditions":324,"interventions":325},"NCT01048047","Effects of Aliskiren\u002FAmlodipine Versus Amlodipine Monotherapy on Ankle-foot Volume in Hypertensive Patients",[62],"2009-12",88,[20],[306],{"trials":327,"activeCount":70},[],{"intervention":275,"totalTrials":66,"cells":329},{"EARLY_PHASE1":330,"PHASE1":332,"PHASE2":334,"PHASE3":336,"PHASE4":338,"NA":344},{"trials":331,"activeCount":70},[],{"trials":333,"activeCount":70},[],{"trials":335,"activeCount":70},[],{"trials":337,"activeCount":70},[],{"trials":339,"activeCount":70},[340],{"nctId":266,"briefTitle":267,"status":252,"phases":341,"primaryCompletion":269,"completion":254,"start":270,"enrollment":271,"conditions":342,"interventions":343},[62],[20,273],[238,275],{"trials":345,"activeCount":70},[],{"intervention":347,"totalTrials":66,"cells":348},"Losartan + Simvastatin",{"EARLY_PHASE1":349,"PHASE1":351,"PHASE2":353,"PHASE3":355,"PHASE4":357,"NA":369},{"trials":350,"activeCount":70},[],{"trials":352,"activeCount":70},[],{"trials":354,"activeCount":70},[],{"trials":356,"activeCount":70},[],{"trials":358,"activeCount":70},[359],{"nctId":360,"briefTitle":361,"status":252,"phases":362,"primaryCompletion":363,"completion":364,"start":363,"enrollment":365,"conditions":366,"interventions":367},"NCT00669435","Losartan and Simvastatin in Hypertensive Obeses With Liver Steatosis",[62],"2008-04","2009-04",75,[20],[347,368],"Amlodipine + Simvastatin",{"trials":370,"activeCount":70},[],{"intervention":368,"totalTrials":66,"cells":372},{"EARLY_PHASE1":373,"PHASE1":375,"PHASE2":377,"PHASE3":379,"PHASE4":381,"NA":387},{"trials":374,"activeCount":70},[],{"trials":376,"activeCount":70},[],{"trials":378,"activeCount":70},[],{"trials":380,"activeCount":70},[],{"trials":382,"activeCount":70},[383],{"nctId":360,"briefTitle":361,"status":252,"phases":384,"primaryCompletion":363,"completion":364,"start":363,"enrollment":365,"conditions":385,"interventions":386},[62],[20],[347,368],{"trials":388,"activeCount":70},[],{"intervention":390,"totalTrials":66,"cells":391},"Dabigatran",{"EARLY_PHASE1":392,"PHASE1":394,"PHASE2":396,"PHASE3":398,"PHASE4":400,"NA":418},{"trials":393,"activeCount":70},[],{"trials":395,"activeCount":70},[],{"trials":397,"activeCount":70},[],{"trials":399,"activeCount":70},[],{"trials":401,"activeCount":70},[402],{"nctId":403,"briefTitle":404,"status":294,"phases":405,"primaryCompletion":406,"completion":407,"start":408,"enrollment":409,"conditions":410,"interventions":412},"NCT02935855","ORal anticoaGulants in diAbetic and Nondiabetic Patients With nOn-valvular Atrial fibrillatioN (ORGANON)",[62],"2019-04","2019-09","2015-09",300,[411],"Diabetes",[390,413,414,415,416,417],"Apixaban","Rivaroxaban","Edoxaban","Warfarin","Acenocumarole",{"trials":419,"activeCount":70},[],{"intervention":413,"totalTrials":66,"cells":421},{"EARLY_PHASE1":422,"PHASE1":424,"PHASE2":426,"PHASE3":428,"PHASE4":430,"NA":436},{"trials":423,"activeCount":70},[],{"trials":425,"activeCount":70},[],{"trials":427,"activeCount":70},[],{"trials":429,"activeCount":70},[],{"trials":431,"activeCount":70},[432],{"nctId":403,"briefTitle":404,"status":294,"phases":433,"primaryCompletion":406,"completion":407,"start":408,"enrollment":409,"conditions":434,"interventions":435},[62],[411],[390,413,414,415,416,417],{"trials":437,"activeCount":70},[],{"intervention":414,"totalTrials":66,"cells":439},{"EARLY_PHASE1":440,"PHASE1":442,"PHASE2":444,"PHASE3":446,"PHASE4":448,"NA":454},{"trials":441,"activeCount":70},[],{"trials":443,"activeCount":70},[],{"trials":445,"activeCount":70},[],{"trials":447,"activeCount":70},[],{"trials":449,"activeCount":70},[450],{"nctId":403,"briefTitle":404,"status":294,"phases":451,"primaryCompletion":406,"completion":407,"start":408,"enrollment":409,"conditions":452,"interventions":453},[62],[411],[390,413,414,415,416,417],{"trials":455,"activeCount":70},[],{"intervention":415,"totalTrials":66,"cells":457},{"EARLY_PHASE1":458,"PHASE1":460,"PHASE2":462,"PHASE3":464,"PHASE4":466,"NA":472},{"trials":459,"activeCount":70},[],{"trials":461,"activeCount":70},[],{"trials":463,"activeCount":70},[],{"trials":465,"activeCount":70},[],{"trials":467,"activeCount":70},[468],{"nctId":403,"briefTitle":404,"status":294,"phases":469,"primaryCompletion":406,"completion":407,"start":408,"enrollment":409,"conditions":470,"interventions":471},[62],[411],[390,413,414,415,416,417],{"trials":473,"activeCount":70},[],{"intervention":416,"totalTrials":66,"cells":475},{"EARLY_PHASE1":476,"PHASE1":478,"PHASE2":480,"PHASE3":482,"PHASE4":484,"NA":490},{"trials":477,"activeCount":70},[],{"trials":479,"activeCount":70},[],{"trials":481,"activeCount":70},[],{"trials":483,"activeCount":70},[],{"trials":485,"activeCount":70},[486],{"nctId":403,"briefTitle":404,"status":294,"phases":487,"primaryCompletion":406,"completion":407,"start":408,"enrollment":409,"conditions":488,"interventions":489},[62],[411],[390,413,414,415,416,417],{"trials":491,"activeCount":70},[],{"intervention":417,"totalTrials":66,"cells":493},{"EARLY_PHASE1":494,"PHASE1":496,"PHASE2":498,"PHASE3":500,"PHASE4":502,"NA":508},{"trials":495,"activeCount":70},[],{"trials":497,"activeCount":70},[],{"trials":499,"activeCount":70},[],{"trials":501,"activeCount":70},[],{"trials":503,"activeCount":70},[504],{"nctId":403,"briefTitle":404,"status":294,"phases":505,"primaryCompletion":406,"completion":407,"start":408,"enrollment":409,"conditions":506,"interventions":507},[62],[411],[390,413,414,415,416,417],{"trials":509,"activeCount":70},[],{"intervention":511,"totalTrials":66,"cells":512},"valsartan\u002Famlodpine",{"EARLY_PHASE1":513,"PHASE1":515,"PHASE2":517,"PHASE3":519,"PHASE4":521,"NA":533},{"trials":514,"activeCount":70},[],{"trials":516,"activeCount":70},[],{"trials":518,"activeCount":70},[],{"trials":520,"activeCount":70},[],{"trials":522,"activeCount":70},[523],{"nctId":524,"briefTitle":525,"status":252,"phases":526,"primaryCompletion":527,"completion":527,"start":528,"enrollment":529,"conditions":530,"interventions":531},"NCT00716950","Valsartan and Amlodipine Compared to Losartan and Amlodipine in Hypertensive Patients",[62],"2009-02","2008-07",187,[23],[511,532],"losartan\u002Famlodpine",{"trials":534,"activeCount":70},[],{"intervention":532,"totalTrials":66,"cells":536},{"EARLY_PHASE1":537,"PHASE1":539,"PHASE2":541,"PHASE3":543,"PHASE4":545,"NA":551},{"trials":538,"activeCount":70},[],{"trials":540,"activeCount":70},[],{"trials":542,"activeCount":70},[],{"trials":544,"activeCount":70},[],{"trials":546,"activeCount":70},[547],{"nctId":524,"briefTitle":525,"status":252,"phases":548,"primaryCompletion":527,"completion":527,"start":528,"enrollment":529,"conditions":549,"interventions":550},[62],[23],[511,532],{"trials":552,"activeCount":70},[],{"intervention":554,"totalTrials":66,"cells":555},"Canrenone 50 vs canrenone 100 mg",{"EARLY_PHASE1":556,"PHASE1":558,"PHASE2":560,"PHASE3":562,"PHASE4":564,"NA":575},{"trials":557,"activeCount":70},[],{"trials":559,"activeCount":70},[],{"trials":561,"activeCount":70},[],{"trials":563,"activeCount":70},[],{"trials":565,"activeCount":70},[566],{"nctId":567,"briefTitle":568,"status":294,"phases":569,"primaryCompletion":570,"completion":571,"start":256,"enrollment":572,"conditions":573,"interventions":574},"NCT02687178","Canrenone as Add-on in Patients With Essential Hypertension",[62],"2015-10","2016-01",180,[23],[554],{"trials":576,"activeCount":70},[],{"intervention":578,"totalTrials":66,"cells":579},"Metformin",{"EARLY_PHASE1":580,"PHASE1":582,"PHASE2":584,"PHASE3":586,"PHASE4":588,"NA":602},{"trials":581,"activeCount":70},[],{"trials":583,"activeCount":70},[],{"trials":585,"activeCount":70},[],{"trials":587,"activeCount":70},[],{"trials":589,"activeCount":70},[590],{"nctId":591,"briefTitle":592,"status":252,"phases":593,"primaryCompletion":594,"completion":595,"start":596,"enrollment":597,"conditions":598,"interventions":599},"NCT01895569","Triple Therapy in Type 2 Diabetic Patients",[62],"2014-06","2016-06","2013-06",64,[259],[578,600,601],"Pioglitazone","Sitagliptin",{"trials":603,"activeCount":70},[],{"intervention":600,"totalTrials":66,"cells":605},{"EARLY_PHASE1":606,"PHASE1":608,"PHASE2":610,"PHASE3":612,"PHASE4":614,"NA":620},{"trials":607,"activeCount":70},[],{"trials":609,"activeCount":70},[],{"trials":611,"activeCount":70},[],{"trials":613,"activeCount":70},[],{"trials":615,"activeCount":70},[616],{"nctId":591,"briefTitle":592,"status":252,"phases":617,"primaryCompletion":594,"completion":595,"start":596,"enrollment":597,"conditions":618,"interventions":619},[62],[259],[578,600,601],{"trials":621,"activeCount":70},[],{"intervention":601,"totalTrials":66,"cells":623},{"EARLY_PHASE1":624,"PHASE1":626,"PHASE2":628,"PHASE3":630,"PHASE4":632,"NA":638},{"trials":625,"activeCount":70},[],{"trials":627,"activeCount":70},[],{"trials":629,"activeCount":70},[],{"trials":631,"activeCount":70},[],{"trials":633,"activeCount":70},[634],{"nctId":591,"briefTitle":592,"status":252,"phases":635,"primaryCompletion":594,"completion":595,"start":596,"enrollment":597,"conditions":636,"interventions":637},[62],[259],[578,600,601],{"trials":639,"activeCount":70},[],{"intervention":262,"totalTrials":239,"cells":641},{"EARLY_PHASE1":642,"PHASE1":644,"PHASE2":646,"PHASE3":648,"PHASE4":664,"NA":666},{"trials":643,"activeCount":70},[],{"trials":645,"activeCount":70},[],{"trials":647,"activeCount":70},[],{"trials":649,"activeCount":70},[650,654],{"nctId":250,"briefTitle":251,"status":252,"phases":651,"primaryCompletion":254,"completion":255,"start":256,"enrollment":257,"conditions":652,"interventions":653},[61],[20,259,260],[238,262],{"nctId":655,"briefTitle":656,"status":252,"phases":657,"primaryCompletion":658,"completion":659,"start":658,"enrollment":660,"conditions":661,"interventions":662},"NCT00644475","Imidapril and Candesartan on Fibrinolysis and Insulin-Sensitivity in Patients With Mild to Moderate Hypertension",[61],"2008-03","2009-03",60,[23],[262,663],"Candesartan",{"trials":665,"activeCount":70},[],{"trials":667,"activeCount":70},[],{"intervention":669,"totalTrials":66,"cells":670},"Losartan",{"EARLY_PHASE1":671,"PHASE1":673,"PHASE2":675,"PHASE3":677,"PHASE4":688,"NA":690},{"trials":672,"activeCount":70},[],{"trials":674,"activeCount":70},[],{"trials":676,"activeCount":70},[],{"trials":678,"activeCount":70},[679],{"nctId":680,"briefTitle":681,"status":252,"phases":682,"primaryCompletion":363,"completion":364,"start":363,"enrollment":683,"conditions":684,"interventions":686},"NCT00659451","Effects Of Losartan On Myocardial Structure In Diabetic Hypertensive Patients With Left Ventricular",[61],100,[23,685],"Diabetes Mellitus",[669,687],"Amlodipine",{"trials":689,"activeCount":70},[],{"trials":691,"activeCount":70},[],{"intervention":687,"totalTrials":66,"cells":693},{"EARLY_PHASE1":694,"PHASE1":696,"PHASE2":698,"PHASE3":700,"PHASE4":706,"NA":708},{"trials":695,"activeCount":70},[],{"trials":697,"activeCount":70},[],{"trials":699,"activeCount":70},[],{"trials":701,"activeCount":70},[702],{"nctId":680,"briefTitle":681,"status":252,"phases":703,"primaryCompletion":363,"completion":364,"start":363,"enrollment":683,"conditions":704,"interventions":705},[61],[23,685],[669,687],{"trials":707,"activeCount":70},[],{"trials":709,"activeCount":70},[],{"intervention":663,"totalTrials":66,"cells":711},{"EARLY_PHASE1":712,"PHASE1":714,"PHASE2":716,"PHASE3":718,"PHASE4":724,"NA":726},{"trials":713,"activeCount":70},[],{"trials":715,"activeCount":70},[],{"trials":717,"activeCount":70},[],{"trials":719,"activeCount":70},[720],{"nctId":655,"briefTitle":656,"status":252,"phases":721,"primaryCompletion":658,"completion":659,"start":658,"enrollment":660,"conditions":722,"interventions":723},[61],[23],[262,663],{"trials":725,"activeCount":70},[],{"trials":727,"activeCount":70},[],{"intervention":729,"totalTrials":239,"cells":730},"MicroRepair ABX mouthwash",{"EARLY_PHASE1":731,"PHASE1":733,"PHASE2":735,"PHASE3":737,"PHASE4":739,"NA":741},{"trials":732,"activeCount":70},[],{"trials":734,"activeCount":70},[],{"trials":736,"activeCount":70},[],{"trials":738,"activeCount":70},[],{"trials":740,"activeCount":70},[],{"trials":742,"activeCount":70},[743,754],{"nctId":744,"briefTitle":745,"status":294,"phases":746,"primaryCompletion":747,"completion":748,"start":749,"enrollment":86,"conditions":750,"interventions":752},"NCT07088653","MicroRepair® ABX vs Chlorhexidine 0.12% in Gingivitis Patients",[63],"2026-02-28","2026-03-10","2025-08-30",[129,26,751],"Gingival Inflammation",[729,753],"Chlorhexidine 0.12% mouthwash",{"nctId":755,"briefTitle":756,"status":294,"phases":757,"primaryCompletion":747,"completion":748,"start":749,"enrollment":86,"conditions":758,"interventions":761},"NCT07088666","0.2% Chlorhexidine vs MicroRepair ABX in Gingivitis",[63],[759,26,760],"Gingivitis and Periodontal Diseases","Oral Hygiene",[729,762],"Chlorhexidine 0.2% mouthwash",{"intervention":753,"totalTrials":66,"cells":764},{"EARLY_PHASE1":765,"PHASE1":767,"PHASE2":769,"PHASE3":771,"PHASE4":773,"NA":775},{"trials":766,"activeCount":70},[],{"trials":768,"activeCount":70},[],{"trials":770,"activeCount":70},[],{"trials":772,"activeCount":70},[],{"trials":774,"activeCount":70},[],{"trials":776,"activeCount":70},[777],{"nctId":744,"briefTitle":745,"status":294,"phases":778,"primaryCompletion":747,"completion":748,"start":749,"enrollment":86,"conditions":779,"interventions":780},[63],[129,26,751],[729,753],{"intervention":782,"totalTrials":66,"cells":783},"Potassium Nitrate Gel",{"EARLY_PHASE1":784,"PHASE1":786,"PHASE2":788,"PHASE3":790,"PHASE4":792,"NA":794},{"trials":785,"activeCount":70},[],{"trials":787,"activeCount":70},[],{"trials":789,"activeCount":70},[],{"trials":791,"activeCount":70},[],{"trials":793,"activeCount":70},[],{"trials":795,"activeCount":70},[796],{"nctId":797,"briefTitle":798,"status":294,"phases":799,"primaryCompletion":800,"completion":801,"start":802,"enrollment":803,"conditions":804,"interventions":806},"NCT06967818","Combined Use of Potassium Nitrate Gel and Diode Laser for Dentin Hypersensitivity",[63],"2025-12-10","2026-01-10","2025-07-15",23,[805],"Dentin Hypersensitivity",[782],{"intervention":808,"totalTrials":66,"cells":809},"local anaesthetic",{"EARLY_PHASE1":810,"PHASE1":812,"PHASE2":814,"PHASE3":816,"PHASE4":818,"NA":820},{"trials":811,"activeCount":70},[],{"trials":813,"activeCount":70},[],{"trials":815,"activeCount":70},[],{"trials":817,"activeCount":70},[],{"trials":819,"activeCount":70},[],{"trials":821,"activeCount":70},[822],{"nctId":823,"briefTitle":824,"status":294,"phases":825,"primaryCompletion":826,"completion":826,"start":827,"enrollment":828,"conditions":829,"interventions":832},"NCT05531435","Local Anesthesia With Computerized Device for Restorative Procedures in Pediatric Patients",[63],"2022-09-21","2022-09-07",30,[830,831],"Dental Pain and Sensation Disorder","Dental Caries in Children",[808],{"intervention":834,"totalTrials":66,"cells":835},"Anti-hypertensive drugs",{"EARLY_PHASE1":836,"PHASE1":838,"PHASE2":840,"PHASE3":842,"PHASE4":844,"NA":846},{"trials":837,"activeCount":70},[],{"trials":839,"activeCount":70},[],{"trials":841,"activeCount":70},[],{"trials":843,"activeCount":70},[],{"trials":845,"activeCount":70},[],{"trials":847,"activeCount":70},[848],{"nctId":849,"briefTitle":850,"status":252,"phases":851,"primaryCompletion":852,"start":853,"conditions":854,"interventions":855},"NCT02064218","Emerging Biomarkers in Hypertension",[],"2014-01","2007-11",[20],[834],{"intervention":762,"totalTrials":66,"cells":857},{"EARLY_PHASE1":858,"PHASE1":860,"PHASE2":862,"PHASE3":864,"PHASE4":866,"NA":868},{"trials":859,"activeCount":70},[],{"trials":861,"activeCount":70},[],{"trials":863,"activeCount":70},[],{"trials":865,"activeCount":70},[],{"trials":867,"activeCount":70},[],{"trials":869,"activeCount":70},[870],{"nctId":755,"briefTitle":756,"status":294,"phases":871,"primaryCompletion":747,"completion":748,"start":749,"enrollment":86,"conditions":872,"interventions":873},[63],[759,26,760],[729,762],{"intervention":875,"totalTrials":66,"cells":876},"DPP-4 inhibitors",{"EARLY_PHASE1":877,"PHASE1":879,"PHASE2":881,"PHASE3":883,"PHASE4":885,"NA":887},{"trials":878,"activeCount":70},[],{"trials":880,"activeCount":70},[],{"trials":882,"activeCount":70},[],{"trials":884,"activeCount":70},[],{"trials":886,"activeCount":70},[],{"trials":888,"activeCount":70},[889],{"nctId":890,"briefTitle":891,"status":294,"phases":892,"primaryCompletion":893,"completion":894,"start":895,"enrollment":896,"conditions":897,"interventions":899},"NCT03486964","Use of Incretins in Diabetic Patients",[],"2020-12-31","2021-05-30","2018-03-27",2234,[898],"Diabetes Mellitus, Type 2",[875],{"intervention":901,"totalTrials":66,"cells":902},"Canrenone",{"EARLY_PHASE1":903,"PHASE1":905,"PHASE2":907,"PHASE3":909,"PHASE4":911,"NA":913},{"trials":904,"activeCount":70},[],{"trials":906,"activeCount":70},[],{"trials":908,"activeCount":70},[],{"trials":910,"activeCount":70},[],{"trials":912,"activeCount":70},[],{"trials":914,"activeCount":70},[915],{"nctId":916,"briefTitle":917,"status":294,"phases":918,"primaryCompletion":919,"completion":920,"start":921,"enrollment":922,"conditions":923,"interventions":925},"NCT03263962","Canrenone Effects on Cardiovascular Mortality in Patients With Congestive Heart Failure (the Coffee-it Study)",[],"2017-09-10","2017-11-30","2017-07-13",502,[924],"Cardiac Heart Failure Patients",[901]]